| Protocol No. | Title | Status |
| 00-0426-04 | PHASE II STUDY OF DIFFUSION MRI AS A PREDICTOR OF CHEMOTHEAPEUTIC RESPONSE IN PATIENTS WITH DIAGNOSED METASTATIC BREAST CANCER (ORIGINAL TITLE: QUANTIFICATION OF HUMAN TUMOR THERAPY RESPONSE BY DIFFUSION MRI | Open |
| 06-0101-03 | Sentinel Lymph Node Working Group Data Acquisition Project | Open |
| 06-0477-04 | DATABASE FOR INDIVIDUALS AT HIGH RISK FOR BREAST, OVARIAN AND OTHER HEREDITARY CANCERS | Open |
| 08-0099-04 | BREAST MAMMOGRAPHIC DENSITY MEASUREMENT: COMPARISON OF RADIOGRAPHIC AND DIFFUSION MRI IMAGING TECHNIQUES | Open |
| 08-0599-04 | Use of Remnant Skin from Mastectomy for Development of Skin Cancer Biomarkers | Open |
| 09-0776-04 | Education and Screening Regarding BRCA1/2 Mutations and Associated Cancer Risks to the Underserved Urban, Rural, and Latina Populations at High Risk for Hereditary Breast Cancer in Arizona via Tele-Genetic Counseling | Open |
| 10-0366-04 | Evaluation of Diindolylmethane Supplementation to Modulate Tamoxifen Efficacy in Breast Cancer | Open |
| 10-0478-04 | I-SPY 2 TRIAL : (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2) | Open |
| 10-0884-04 | A Phase I Trial of Weekly Paclitaxel in Combination with Bavituximab in Patients with Her-2 Negative Metastatic Breast Cancer | Open |
| 11-0607-10 | A phase III Trial of Accelerated Whole Breast Irradiation with Hypofractionation Plus Concurrent Boost Versus Standard Whole Breast Irradiation Plus Sequential Boost for Early-stage Breast Cancer RTOG 1005 | Open |
| 12-0138-04 | Biospecimen Repository for Individuals at High Risk for Breast, Ovarian, or Other Hereditary Cancers | Open |
| 12-0513-04 | S1008 Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase II | Open |
| 13-0154-10 | E2108 A Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer | Open |
| 20081765 | An Open-Label Study of AMG 386 in Combination with Either Paclitaxel or Trastuzumab or Capecitabine and Lapatinib in Subjects with Her2-positive Locally Recurrent or Metastatic Breast Cancer | Open |
| 20121111 | A two-cohort, open-label, multicenter Phase II trial assessing the efficacy and safety of pertuzumab given in combination with trastuzumab and vinorelbine in first line patients with HER2-positive advanced (metastatic or locally advanced) breast cancer. | Open |
| 20121367 | A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BEVACIZUMAB, AND ASSOCIATED BIOMARKERS, IN COMBINATION WITH PACLITAXEL COMPARED WITH PACLITAXEL PLUS PLACEBO AS FIRST LINE TREATMENT OF PATIENTS WITH HER2-NEGATIVE METASTATIC BREAST CANCER
| Open |